Literature DB >> 63468

Androgens in patients with benign prostatic hyperplasia before and after prostatectomy.

A Vermeulen, W De Sy.   

Abstract

Plasma androgens [testosterone (T), 17beta-hydroxy-5alpha-androstan-3-one (DHT), androst-4-en-3,17 dione(A), and dehydroepiandrosterone (DHEA)] as well as 17 hydroxyprogesterone were measured in a group of patients (age 60-80 yrs.) with benign prostatic hyperplasia (BPH) just before prostatectomy and compared to values obtained in subjects of similar age without signs of BPH. The most important difference was observed in the mean DHT level which was significantly (P less than 0.025) higher than in the control group; mean T and free testosterone levels in BPH patients were slightly higher (P less than 0.05) in the age group 70-80 yrs; whereas in age group 60-70 mean values were similar to those observed in normal controls. Mean A, DHEA and 17 OHP and E2 levels were not significantly different in BPH patients when compared to age matched controls. 2-5 months after prostatectomy, T and DHT levels were significantly higher than immediately preoperatively. The preoperative stress may have influenced the preprostatectomy values.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 63468     DOI: 10.1210/jcem-43-6-1250

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Concentration of dihydrotestosterone and 3 alpha-androstanediol in naturally occurring and androgen-induced prostatic hyperplasia in the dog.

Authors:  R J Moore; J M Gazak; J F Quebbeman; J D Wilson
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

2.  Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.

Authors:  Alan R Kristal; Jeannette M Schenk; YoonJu Song; Kathryn B Arnold; Marian L Neuhouser; Phyllis J Goodman; Daniel W Lin; Frank Z Stanczyk; Ian M Thompson
Journal:  Am J Epidemiol       Date:  2008-10-21       Impact factor: 4.897

3.  Investigations of serum testosterone levels in patients with laryngeal cancers.

Authors:  R Haidoutova; M Melamed; S Dimitrova; R Kyossovska
Journal:  Arch Otorhinolaryngol       Date:  1985

4.  Serum testosterone and dihydrotestosterone in carcinoma of the prostate.

Authors:  R Ghanadian; C M Puah; E P O'Donoghue
Journal:  Br J Cancer       Date:  1979-06       Impact factor: 7.640

5.  Serum sex steroids, gonadotrophins and sex hormone-binding globulin in prostatic hyperplasia.

Authors:  Mohammad Abdul Jalil Ansari; Dilruba Begum; Fakhrul Islam
Journal:  Ann Saudi Med       Date:  2008 May-Jun       Impact factor: 1.526

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.